Home > Insider Trading > Filing (0001479290-21-000141)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1479290	Revance Therapeutics Inc.	RVNC	Pharmaceutical Preparations (2834)	770551645

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1818576	Aubrey Rankin	C/O Revance Therapeutics, Inc 1222 Demonbreun Street, Suite 2000 Nashville TN 37203	President, Innovation & Tech	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-07-28	34,332	$30.00	321,611	No	4	S	Indirect	Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
Common Stock	Disposition	2021-07-28	20,000	$30.15	154,302	No	4	S	Indirect	The Rankin Irrevocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009
No	4	S	Indirect	The Rankin Irrevocable Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	79,776	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by Mr. Rankin.
The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.02. Mr. Rankin undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.
The sales by the Rankin Irrevocable Trust (the "Trust") reported in this Form 4 were effected pursuant to an executed instruction letter previously provided to the Company by the trustee of the Trust.
The price reported in Table 1, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.01 to $30.35. Mr. Rankin undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
These shares are held by The Rankin Irrevocable Trust, of which the children of Mr. Rankin are beneficiaries.